BNF British National Formulary Chapter 9 Section 1.2 bnf.nice.org.uk/drug/hydrox
Batch: GF082025006 Key analytical results include: Assay Content: 10.49 mg Identification Retention Time: 1.000 Identification Spectrum: 999 Purity: greater than 99.8 percent Bacterial Endotoxins: detected but below 0.01 EU per mg Total Aerobic Microbial Count: not detected Total Yeast and Mold Count: not detected Independent heavy metal screening confirmed no detectable levels of arsenic, cadmium, cobalt, lead, nickel, mercury or vanadium
PDA: Collagen Production and Tissue Repair Main Focus: PDA is designed to stimulate collagen production, which is key for repairing muscles, tendons, ligaments, and bones
Injection Site Selection for Shoulders For rotator cuff and general shoulder issues, inject subcutaneously within one to two inches of the affected area
It turns down overactive inflammation
2.5 mg is always 25 units at 10 mg/mL, whether that solution came from a 5 mg vial or a 30 mg vial